Barclays raised the firm’s price target on Hinge Health (HNGE) to $51 from $43 and keeps an Overweight rating on the shares. The firm adjusted targets in the security, design, and vertical software-as-a-service group as part of an earnings preview.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HNGE: